These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 741221)

  • 21. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H; Drewinko B
    Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic and antagonistic interactions of methotrexate and 1-beta-D-arabinofuranosylcytosine in hepatoma cells. The modulating effect of purines.
    Jackson RC; Harkrader RJ
    Biochem Pharmacol; 1981 Feb; 30(3):223-9. PubMed ID: 7225140
    [No Abstract]   [Full Text] [Related]  

  • 23. Rat hepatomas: chemotherapy with lycurim and pyrazofurin.
    Lui MS; Jackson RC; Harkrader RJ; Weber G
    J Natl Cancer Inst; 1982 Apr; 68(4):665-8. PubMed ID: 6951080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
    Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
    Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
    Ritch PS; Occhipinti SJ; Cunningham RE; Shackney SE
    Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Close reproduction by different laboratories of characteristics of circadian rhythm in 1-beta-D-arabinofuranosylcytosine tolerance by mice.
    Scheving LE; Haus E; Kühl JF; Pauly JE; Halberg F; Cardoso S
    Cancer Res; 1976 Mar; 36(3):1133-7. PubMed ID: 1253172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of hypoplastic leukemia--clinical effects of low-dose 4N-behenoyl-beta-D-arabinofuranosylcytosine (BH-AC) therapy].
    Nakada H; Takahashi I; Yorimitu S; Hara M; Ohmoto E; Inagaki T; Aoyama S; Nishimura M; Hayashi N; Sekito N
    Rinsho Ketsueki; 1987 Apr; 28(4):534-40. PubMed ID: 3476764
    [No Abstract]   [Full Text] [Related]  

  • 28. Continuous infusion of high-dose 1-beta-D-arabinofuranosylcytosine: a phase I and pharmacological study.
    Spriggs DR; Robbins G; Takvorian T; Kufe DW
    Cancer Res; 1985 Aug; 45(8):3932-6. PubMed ID: 4016760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing 1-beta-D-arabinofuranosylcytosine efficacy by scheduled dosing intervals based on direct measurements of bone marrow cell kinetics.
    Ubezio P; Tagliabue G; Schechter B; Agur Z
    Cancer Res; 1994 Dec; 54(24):6446-51. PubMed ID: 7987841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antitumor effect of a novel nitrosourea, tauromustine, at intravenous administration in rat. Cure of hepatomas.
    Roos G; el Hag IA; Christensson PI; Stenram U
    Anticancer Res; 1991; 11(5):1763-6. PubMed ID: 1837442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of two sequential applications of initiators in the production of hepatomas in the rat: an examination of the Solt-Farber protocol.
    Potter VR
    Cancer Res; 1984 Jun; 44(6):2733-6. PubMed ID: 6722804
    [No Abstract]   [Full Text] [Related]  

  • 32. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
    Chandrasekaran B; Capizzi RL; Kute TE; Morgan T; Dimling J
    Cancer Res; 1989 Jun; 49(12):3259-66. PubMed ID: 2720678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules.
    Kline I; Venditti JM; Tyrer DD; Goldin A
    Cancer Res; 1966 May; 26(5):853-9. PubMed ID: 5936445
    [No Abstract]   [Full Text] [Related]  

  • 34. Antitumor activity of 2,6-bis(halomethyl)piperidines on rat ascites hepatomas.
    Miyamoto K; Sanae F; Koshiura R
    Gan; 1978 Oct; 69(5):703-7. PubMed ID: 729968
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and pharmacokinetic studies of high dose N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
    Yoshida T; Nakamura S; Ohtake S; Ito K; Kobayashi K; Kanno M; Hirai J; Tachimori K; Matsuda T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1820-4. PubMed ID: 3592717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W; Liliemark JO; Adams TM; Nowak B; Estey E; Kantarjian H; Keating MJ
    Cancer Res; 1987 Jun; 47(11):3005-11. PubMed ID: 3471322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The antitumor activity of intraperitoneally- or orally-administered etoposide in animals and its administration-schedule dependency].
    Okamoto K; Nishikawa K; Seki T; Shibasaki C; Uchida T; Takahashi K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2331-7. PubMed ID: 4073928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on pools of deoxyribonucleoside triphosphates in L1210 ascites cells.
    Roberts D; Peck C
    Cancer Res; 1981 Feb; 41(2):505-10. PubMed ID: 7448798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A model for the chemotherapy of acute leukemia with 1-beta-D-arabinofuranosylcytosine.
    Momparler RL
    Cancer Res; 1974 Aug; 34(8):1775-87. PubMed ID: 4526298
    [No Abstract]   [Full Text] [Related]  

  • 40. [Loco-regional cancer chemotherapy with a new drug delivery system, "anticancer drug-fibrin clot"].
    Sugitachi A; Takatsuka Y; Numata N; Kawahara T; Hirata M; Kido T; Sakamoto I
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2814-7. PubMed ID: 2782891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.